Sodium acid heparin (CAS 9041-08-1) Market Research Report 2024

April 2024 | 50 pages | ID: SB0BD4D5095EN
BAC Reports

Abstracts

Sodium acid heparin (CAS 9041-08-1) Market Research Report 2024 presents comprehensive data on Sodium acid heparin markets globally and regionally (Europe, Asia, North America etc.)

The report includes Sodium acid heparin description, covers its application areas and related patterns. It overviews Sodium acid heparin market, names Sodium acid heparin producers and indicates its suppliers.

Besides, the report provides Sodium acid heparin prices in regional markets.

In addition to the above the report determines Sodium acid heparin consumers in the market.

BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).

We can analyze the following elements for each chemical product in any country or region:

• capacities and production
• consumption volume and structure
• market price trends
• exports and imports
• existing technologies
• feedstock market condition
• market news digest
• market forecast.

Sodium acid heparin (CAS 9041-08-1) Market Research Report 2024 can feature:

• market condition and estimations, market forecast
• chemical product ranges, trademarks, analogous products, application areas
• regional and global producers, consumers and traders (including contact details).

Contents

1. SODIUM ACID HEPARIN (CAS 9041-08-1)

1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. SODIUM ACID HEPARIN APPLICATIONS

2.1. Sodium acid heparin application spheres, downstream products

3. SODIUM ACID HEPARIN MANUFACTURING METHODS

4. SODIUM ACID HEPARIN PATENTS

Abstract
Description
Summary of the invention
Detailed description of the invention

5. SODIUM ACID HEPARIN MARKET WORLDWIDE 

5.1. General Sodium acid heparin market situation, trends
5.2. Manufacturers of Sodium acid heparin
- Europe
- Asia
- North America
- Other regions
5.3. Sodium acid heparin suppliers (importers, local distributors)
- Europe
- Asia
- North America
- Other regions
5.4. Sodium acid heparin market forecast

6. SODIUM ACID HEPARIN MARKET PRICES

6.1. Sodium acid heparin prices in Europe
6.2. Sodium acid heparin prices in Asia
6.3. Sodium acid heparin prices in North America
6.4. Sodium acid heparin prices in other regions

7. SODIUM ACID HEPARIN END-USE SECTOR 

7.1. Sodium acid heparin market by application sphere
7.2. Sodium acid heparin downstream markets trends and prospects

*Please note that Sodium acid heparin (CAS 9041-08-1) Market Research Report 2024 is a half ready publication and contents are subject to change. It only requires updating with the help of new data that are constantly retrieved from Publisher’s databases and other sources. This updating process takes 5-7 business days after order is placed. Thus, our clients always obtain a revised and updated version of each report. Please also note that we do not charge for such an updating procedure. BAC Reports has information for more than 25,000 different chemicals available but it is impossible to have all reports updated immediately. That is why it takes 5-7 days to update a report after an order is received.

About

Product Name:	Sodium acid heparin
Synonyms:	Ardeparin sodium Dalteparin sodium Enoxaparin sodium Heparin,compounds,sodium salt Heparin HEPARIN SODIUM SALT Heparin Sodium Heparin Sodium BP Heparin sodium,low molecular weight heparins
CAS#:	9041-08-1
Formula:	(C12H16NS2Na3)20
Appearance:	Odorless white to off-white solid or liquid
Usage:	Anticlotting agent.

Heparin sodium (Alfa87-120; Alfa 87-163; Alfa 87-198; Alfa 87-81; Alfa 88-247; Ardeparin sodium; Badyket; Clivarin 1750; Fragmin; Fragmin IV; H 2149; Hed-Heparin; Hepaflush; Hepagumin; Hepalean; Heparin Fragment Kabi 2165; Heparin sodium; HeparineChoay; Heprinar; Hepsal; Ivor; Kabi 2165; LHN 1; Lioton1000; etc.) refers to a complex glycosaminoglycan that is composed of alternate sequences of uronic acid -D-glucosamine linked by bonds. In heparin sodium, the acidic protons of the sulfate units are partially replaced by sodium ions.

Heparin sodium is a white odorless solid with the molecular formula (C₁₂H₁₆NS₂Na₃)20. The product is 5% soluble in water.

Heparin sodium exhibits a lot of uses, however, it is most widely used as an anticoagulant. The product is utilized to prevent or decrease blood clotting during different kinds of surgeries and during dialysis. Heparin sodium prevents clots of blood from forming and becoming larger. Furthermore, the product is used in veterinary for treatment of thromboembolic disease, pancreatitis, laminitis, endotoxic shock and burns. The treatment of acute phase myocardial infartus, pulmonary embolism, atherosclerosis, deep phlebitis, etc. are amid other applications of heparin sodium.

The product causes potential health effects such as transient eye irritation, hemorrhage at multiple sites, respiratory and kidney abnormalities, anemia, and cardiovascular collapse. Gastrointestinal irritation, nausea, vomiting and diarrhea are also amid the side effects of heparin sodium.

Heparin sodium market is covered in the study Heparin sodium, low molecular weight heparins (CAS 9041-08-1) Market Research Report 2013. The report encompasses proper description of the product, unveils application areas, and briefly summarizes patents in the sphere. It overlooks heparin sodium market situation, names manufacturers, suppliers as well as users. The report also provides current heparin sodium prices in the market.